Monica Hermanson

Migrating to Long-Read Sequencing for Clinical Routine BCR-ABL1 TKI Resistance Mutation Screening

Schaal, Wesley; Ameur, Adam; Olsson-Strömberg, Ulla; Hermansson, Monica et al.

Ingår i Cancer Informatics, s. 1-8, 2022

• DOI för Migrating to Long-Read Sequencing for Clinical Routine BCR-ABL1 TKI Resistance Mutation Screening
• Ladda ner fulltext (pdf) av Migrating to Long-Read Sequencing for Clinical Routine BCR-ABL1 TKI Resistance Mutation Screening

Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting

Pandzic, Tatjana; Ladenvall, Claes; Engvall, Marie; Mattsson, Mattias et al.

Ingår i HemaSphere, 2022

• DOI för Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting
• Ladda ner fulltext (pdf) av Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting

Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1

Pfeifer, H.; Cazzaniga, G.; van der Velden, V. H. J.; Cayuele, J. M. et al.

Ingår i Leukemia, s. 1910-1922, 2019

• DOI för Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1

Flow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia

Löf, Liza; Arngården, Linda; Olsson-Strömberg, Ulla; Siart, Benjamin et al.

Ingår i Scientific Reports, s. 1-9, 2017

• DOI för Flow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia
• Ladda ner fulltext (pdf) av Flow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia

Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis

Mosrati, Mohamed Ali; Willander, Kerstin; Falk, Ingrid Jakobsen; Hermanson, Monica et al.

Ingår i Oncotarget, s. 25109-25120, 2015

• Ladda ner fulltext (pdf) av Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis

Migrating to Long-Read Sequencing for Clinical Routine BCR-ABL1 TKI Resistance Mutation Screening

Schaal, Wesley; Ameur, Adam; Olsson-Strömberg, Ulla; Hermansson, Monica et al.

Ingår i Cancer Informatics, s. 1-8, 2022

• DOI för Migrating to Long-Read Sequencing for Clinical Routine BCR-ABL1 TKI Resistance Mutation Screening
• Ladda ner fulltext (pdf) av Migrating to Long-Read Sequencing for Clinical Routine BCR-ABL1 TKI Resistance Mutation Screening

Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting

Pandzic, Tatjana; Ladenvall, Claes; Engvall, Marie; Mattsson, Mattias et al.

Ingår i HemaSphere, 2022

• DOI för Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting
• Ladda ner fulltext (pdf) av Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting

Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1

Pfeifer, H.; Cazzaniga, G.; van der Velden, V. H. J.; Cayuele, J. M. et al.

Ingår i Leukemia, s. 1910-1922, 2019

• DOI för Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1

Flow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia

Löf, Liza; Arngården, Linda; Olsson-Strömberg, Ulla; Siart, Benjamin et al.

Ingår i Scientific Reports, s. 1-9, 2017

• DOI för Flow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia
• Ladda ner fulltext (pdf) av Flow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia

Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis

Mosrati, Mohamed Ali; Willander, Kerstin; Falk, Ingrid Jakobsen; Hermanson, Monica et al.

Ingår i Oncotarget, s. 25109-25120, 2015

• Ladda ner fulltext (pdf) av Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis

Clonal distribution of BCR-ABL1 mutations and splice isoforms by single-molecule long-read RNA sequencing

Cavelier, Lucia; Ameur, Adam; Häggqvist, Susana; Höijer, Ida et al.

Ingår i BMC Cancer, 2015

• DOI för Clonal distribution of BCR-ABL1 mutations and splice isoforms by single-molecule long-read RNA sequencing
• Ladda ner fulltext (pdf) av Clonal distribution of BCR-ABL1 mutations and splice isoforms by single-molecule long-read RNA sequencing

TP53 mutations and MDM2(SNP309) identify subgroups of AML patients with impaired outcome

Falk, Ingrid Jakobsen; Willander, Kerstin; Chaireti, Roza; Lund, Johan et al.

Ingår i European Journal of Haematology, s. 355-362, 2015

• DOI för TP53 mutations and MDM2(SNP309) identify subgroups of AML patients with impaired outcome

Association of TERT polymorphism with acute myeloid leukemia risk and prognosis

Lotfi, Kourosh; Mosrati, Mohamed Ali; Willander, Kerstin; Falk, Ingrid Jakobsen et al.

Ingår i Cancer Research, 2015

• DOI för Association of TERT polymorphism with acute myeloid leukemia risk and prognosis

Impact of ABCB1 single nucleotide polymorphisms 1236C>T and 2677G>T on overall survival in FLT3 wild-type de novo AML patients with normal karyotype

Falk, Ingrid Jakobsen; Fyrberg, Anna; Paul, Esbjorn; Nahi, Hareth et al.

Ingår i British Journal of Haematology, s. 671-680, 2014

• DOI för Impact of ABCB1 single nucleotide polymorphisms 1236C>T and 2677G>T on overall survival in FLT3 wild-type de novo AML patients with normal karyotype

TP53 mutations and MDM2 single nucleotide polymorphism 309T-G predicts outcome and treatment resistance in acute myeloid leukemia

Falk, Ingrid Jakobsen; Willander, Kerstin; Chaireti, Roza; Lund, Johan et al.

Ingår i Cancer Research, 2014

• DOI för TP53 mutations and MDM2 single nucleotide polymorphism 309T-G predicts outcome and treatment resistance in acute myeloid leukemia

Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5 '-nucleotidase

Falk, Ingrid Jakobsen; Fyrberg, Anna; Paul, Esbjorn; Nahi, Hareth et al.

Ingår i American Journal of Hematology, s. 1001-1006, 2013

• DOI för Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5 '-nucleotidase

Correlation between cytidine deaminase single nucleotide polymorphisms and in vitro drug sensitivity, DNA methylation and outcome in normal karyotype acute myelogenous leukemia

Falk, Ingrid Jakobsen; Fyrberg, Anna; Hermanson, Monica; Höglund, Martin et al.

Ingår i Cancer Research, 2013

• DOI för Correlation between cytidine deaminase single nucleotide polymorphisms and in vitro drug sensitivity, DNA methylation and outcome in normal karyotype acute myelogenous leukemia

The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia

Eriksson, Anna; Hermanson, Monica; Wickström, Malin; Lindhagen, Elin et al.

Ingår i Blood Cancer Journal, 2012

• DOI för The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia

The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation

Lion, T.; Watzinger, F.; Preuner, S.; Kreyenberg, H. et al.

Ingår i Leukemia, s. 1821-1828, 2012

• DOI för The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation

In vitro activity of the flt3-inhibitor su5614 and standard cytotoxic agents in tumour cells from patients with wild type and mutated flt3 acute myeloid leukaemia.

Åleskog, Anna; Höglund, Martin; Pettersson, Jenny; Hermansson, Monica et al.

Ingår i Leuk Res, s. 1079-81, 2005